Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 2.2. It has been cited 110 times, with 72 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.706
From this paper's citation signal
Citation Network Contribution
1.5
From 50 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 72 citers.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: ZIA AI001009-13
Intramural NIH HHS
Grant: ZIA AI001009
National Institutes of Health
Grant: 1ZIAAI001009-11
Malaria Vaccines: Pfs25-rEPA and Pfs230-rEPA
FWCI
16.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals